aktsiaselts SEMETRONRegistered
Annual report for 2025 not filed.
Qualified audit opinion. 2019 report: Qualified.
Key figures
20 006 420 €+10,5%
Revenue 2024
+7,9%
Average annual growth 2019–2024
Ratios
2024−8,2%
Profit margin
−2,4%
EBITDA margin
17,2%
Equity ratio
1,0×
Current ratio
−45,1%
Return on equity
4482 €
Average gross salary
Balance sheet structure
Current assetsNon-current assetsLiabilitiesEquity
Quarterly figures
| Quarter | Revenue | Number of employees | Labour taxes |
|---|---|---|---|
| Q2 2026 | 5 736 937 € | 48 | 360 521 € |
| Q1 2026 | 5 801 991 € | 50 | 359 756 € |
| Q4 2025 | 6 898 376 € | 52 | 381 535 € |
| Q3 2025 | 7 229 213 € | 54 | 422 023 € |
| Q2 2025 | 7 149 408 € | 55 | 393 691 € |
| Q1 2025 | 7 862 816 € | 56 | 374 356 € |
Source: Tax Board open data — based on VAT returns, may not exactly match revenue in the annual report. Updated quarterly.
Summary of financial statements2019–2024
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|
| Balance sheet — assets | ||||||
| Total current assets | 8 700 672 | 4 526 318 | 9 820 243 | 17 399 273 | 12 578 213 | 17 354 392 |
| Total non-current assets | 305 108 | 1 769 530 | 2 138 836 | 1 672 750 | 2 771 288 | 3 896 350 |
| Total assets | 9 005 780 | 6 295 848 | 11 959 079 | 19 072 023 | 15 349 501 | 21 250 742 |
| Balance sheet — liabilities and equity | ||||||
| Current liabilities | 5 512 839 | 4 075 953 | 7 921 901 | 13 392 103 | 8 350 405 | 17 370 936 |
| Non-current liabilities | 164 220 | 102 960 | 210 551 | 68 978 | 1 692 535 | 221 844 |
| Total liabilities | 5 677 059 | 4 178 913 | 8 132 452 | 13 461 081 | 10 042 940 | 17 592 780 |
| Share capital | 486 350 | 486 350 | 486 350 | 486 350 | 486 350 | 486 350 |
| Retained earnings of previous periods | −208 432 | 587 747 | −2 417 333 | −851 847 | 1 761 156 | 628 087 |
| Profit for the year | 796 179 | −3 211 786 | 1 565 486 | 1 784 315 | −1 133 069 | −1 648 599 |
| Reserves and other equity | 2 254 624 | 4 254 624 | 4 192 124 | 4 192 124 | 4 192 124 | 4 192 124 |
| Total equity | 3 328 721 | 2 116 935 | 3 826 627 | 5 610 942 | 5 306 561 | 3 657 962 |
| Income statement | ||||||
| Sales revenue | 13 710 804 | 13 698 112 | 20 665 983 | 30 744 695 | 18 103 478 | 20 006 420 |
| Operating profit | 828 390 | −3 094 673 | 1 731 537 | 1 999 252 | −563 742 | −869 468 |
| EBITDA | 882 412 | −3 034 535 | 1 932 003 | 2 209 016 | −337 001 | −474 219 |
| Profit before income tax | 871 179 | −3 211 786 | 1 565 486 | 1 784 315 | −883 069 | −1 648 599 |
| Profit for the reporting year | 796 179 | −3 211 786 | 1 565 486 | 1 784 315 | −1 133 069 | −1 648 599 |
| Labour costs | 1 569 151 | — | — | — | — | — |
| Depreciation of non-current assets | 54 022 | 60 138 | 200 466 | 209 764 | 226 741 | 395 249 |
| Other indicators | ||||||
| Employees | 41 | 33 | 0 | 0 | 55 | 56 |
| Calculated dividend | — | 0 | 0 | 0 | 0 | 0 |
A dash (—) means the report has not been filed or the line is not reported; 0 is a zero stated in the report.
Connections graph
Click a node to see its other connections.
CompanyPersonShareholderOther roleAdditional link
Related companies
Same activity — Wholesale of medical equipment, surgical instruments and orthopaedic aids